Lung Cancer Trial, Recruiting NCT07584239 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07584239
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC) at a specific stage (stages IB through IIIB, based on the 9th edition staging system) that may be able to be removed with surgery
  • People who are planning to have surgery after receiving pre-surgery treatment (such as chemotherapy or other systemic therapy) through the Thoracic Oncology Clinic at the Ohio State University Comprehensive Cancer Center (OSUCCC)
  • People who are at least 6 weeks away from their planned surgery date
  • People who are willing to take part in and follow the study's program
  • People who are able to understand the study and are willing to sign a consent form agreeing to participate

Who may not be able to join:

  • People who are currently incarcerated (prisoners) are not able to take part
  • People who are already enrolled in another clinical trial testing a new cancer treatment may not be able to join, as this could affect the results of either trial — unless the lead doctor at the trial site gives specific permission

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carolyn J Presley, MD, Ohio State University Comprehensive Cancer Center

Phone: 800-293-5066

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
15 July 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence (feasibility); Retention (feasibility)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov